The consensus based term for a rheumatic joint disorder in childhood is “juvenile idiopathic arthritis (JIA)”, and not “juvenile rheumatic coxitis.” [note: the author points out a mistake ...

Methotrexate (MTX) is the widely agreed upon first-choice second-line agent to treat juvenile idiopathic arthritis (JIA), up to 75% of JIA patients in recent registries have used MTX at some time ...

Biologic therapy reduces TMJ inflammation in children with juvenile arthritis, according to a new study. Findings show ...

Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the ...